Long-term mortality associated with aprotinin following coronary artery bypass graft surgery.
Scharnetzky
Elke
E
Schill
Walter
W
Garbe
Edeltraut
E
D007611:Aprotinin / Q000009:adverse effects / Q000627:therapeutic use*; D001026:Coronary Artery Bypass / Q000401:mortality*; D005060:Europe; D006490:Hemostatics / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009656:North America; D012306:Risk
D006490:Hemostatics; D007611:Aprotinin